The invasive phenotype in HMT-3522 cells requires increased EGF receptor signaling through both PI 3-kinase and ERK 1,2 pathways
- PMID: 12487410
- DOI: 10.1080/15419060214147
The invasive phenotype in HMT-3522 cells requires increased EGF receptor signaling through both PI 3-kinase and ERK 1,2 pathways
Abstract
We studied the invasion of HMT-3522 breast epithelial cells in response to epidermal growth factor (EGF), and the associated signaling pathways. HMT-3522 T4-2 cells were shown to invade Matrigel-coated Transwell membranes in response to EGF while HMT-3522 S-1 cells failed to invade when treated with EGF. Studies utilizing specific molecular inhibitors showed the importance of beta1 integrin, phosphatidylinositol 3 kinase (PI 3-kinase), p38, extracellular regulated kinase 1, 2 (Erk 1,2) MAP kinases, and metalloproteinases in invasion and motility. T4-2 cell invasion was shown to be time-dependent and also gene transcription-dependent as shown by inhibition with Actinomycin D. T4-2 cells exhibited an increased activation of MAP kinases Erk 1,2 (2-fold), EGF receptor (3-fold), and PI 3-kinase (3- to 4-fold) when compared to the S-1 cells. In response to EGF, T4-2 cells showed a 5-fold greater secretion of matrix metalloproteinase-9 (MMP-9) as compared to S-1 cells, and this increase was largely dependent on the activity of PI 3-kinase. These findings indicate that expression of the invasive phenotype in these breast epithelial cells requires increased EGF receptor signaling, involving both PI 3-kinase and Erk 1,2 activities, which leads to multiple downstream effects, including enhanced secretion of MMP-9 and transcription of invasion-related genes.
Similar articles
-
Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells.Int J Cancer. 1999 Jul 19;82(2):268-73. doi: 10.1002/(sici)1097-0215(19990719)82:2<268::aid-ijc18>3.0.co;2-4. Int J Cancer. 1999. PMID: 10389762
-
Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution.J Cell Biol. 2003 Apr 14;161(1):197-209. doi: 10.1083/jcb.200208145. J Cell Biol. 2003. PMID: 12695504 Free PMC article.
-
The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway.J Pharmacol Exp Ther. 2002 Mar;300(3):1026-35. doi: 10.1124/jpet.300.3.1026. J Pharmacol Exp Ther. 2002. PMID: 11861812
-
Oncogenic PI3Kα promotes multipotency in breast epithelial cells.Sci Signal. 2015 Nov 3;8(401):pe3. doi: 10.1126/scisignal.aad5856. Sci Signal. 2015. PMID: 26535006 Free PMC article. Review.
-
Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion.Lab Invest. 2014 Jan;94(1):31-40. doi: 10.1038/labinvest.2013.132. Epub 2013 Nov 18. Lab Invest. 2014. PMID: 24247562 Free PMC article. Review.
Cited by
-
Analysis of activated EGFR signalling pathways and their relation to laminin-5 gamma2 chain expression in oral squamous cell carcinoma (OSCC).Histochem Cell Biol. 2005 Aug;124(2):151-60. doi: 10.1007/s00418-005-0001-4. Epub 2005 Sep 29. Histochem Cell Biol. 2005. PMID: 16052324
-
S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.Tumour Biol. 2016 Sep;37(9):12241-12250. doi: 10.1007/s13277-016-5096-9. Epub 2016 May 30. Tumour Biol. 2016. PMID: 27240591
-
MAP Kinases and Prostate Cancer.J Signal Transduct. 2012;2012:169170. doi: 10.1155/2012/169170. Epub 2011 Oct 20. J Signal Transduct. 2012. PMID: 22046506 Free PMC article.
-
Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.Breast Cancer Res. 2009;11(5):209. doi: 10.1186/bcr2361. Breast Cancer Res. 2009. PMID: 19818165 Free PMC article. Review.
-
ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.Tumour Biol. 2014 Aug;35(8):7575-86. doi: 10.1007/s13277-014-1990-1. Epub 2014 May 4. Tumour Biol. 2014. PMID: 24793016
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous